Measles Mumps and Rubella Vaccines Market

Measles can lead to otitis media, tracheitis, encephalitis and other complications.Mumps can cause hearing loss and inflammation of the ovaries or testes.German measles can lead to arthritis, encephalitis, conjunctivitis, miscarriage or birth defects.
Measles Mumps and Rubella Vaccines Market contains market size and forecasts of Measles, Mumps and Rubella (MMR) Vaccines in global, including the following market information:
Global Measles, Mumps and Rubella (MMR) Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Measles, Mumps and Rubella (MMR) Vaccines Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Measles, Mumps and Rubella (MMR) Vaccines companies in 2021 (%)
The global Measles, Mumps and Rubella (MMR) Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monovalent Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Measles, Mumps and Rubella (MMR) Vaccines include Medlmmune, Johnson & Johnson, Merck, Sanofi, Serum, Bavarian Nordic, Astellas Pharma, Emergent BioSolutions and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Measles, Mumps and Rubella (MMR) Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Measles, Mumps and Rubella (MMR) Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment Percentages, by Type, 2021 (%)
Monovalent Vaccine
Polyvalent Vaccine
Global Measles, Mumps and Rubella (MMR) Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment Percentages, by Application, 2021 (%)
Immune Center
Vaccine Development Agencies and Organizations
Hospital
Laboratory
Biotechnology and Biopharmaceutical Companies
Global Measles, Mumps and Rubella (MMR) Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Measles, Mumps and Rubella (MMR) Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Measles, Mumps and Rubella (MMR) Vaccines revenues share in global market, 2021 (%)
Key companies Measles, Mumps and Rubella (MMR) Vaccines sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Measles, Mumps and Rubella (MMR) Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medlmmune
Johnson & Johnson
Merck
Sanofi
Serum
Bavarian Nordic
Astellas Pharma
Emergent BioSolutions
GlaxoSmithKline
Pfizer
CSL